You are here: Industry Insights > Vaccine

News List

India has robust manufacturing capability with sufficient skilled manpower to foster innovation ExpressPharma
November 19, 2021
Give us an overview of the major advancements, shifts and trends in healthcare and lifesciences due to the COVID-19 pandemic. How will these spur investments in the research and manufacturing of biopharmaceuticals in India?
New Data Suggests More Doctors Spending Time Addressing COVID-19 Vaccine Misinformation As Compared To Six Months Ago B3Cnewswire
November 18, 2021
Sermo’s most recent COVID-19 Real Time Barometer surveyed 3,050 physicians across 26 countries and showed that while more physicians are hearing fewer concerns from patients about the side effects of the vaccine...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines prnewswire
November 18, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII)...
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...
Health Canada approves Moderna’s Covid-19 vaccine booster shot Pharmaceutical-Business-Review
November 17, 2021
Health Canada has authorised the booster shot of Moderna’s Covid-19 vaccine, Spikevax, for individuals aged 18 years and above.
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world WorldPharmaNews
November 17, 2021
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months.
Alcami Inks Lab Services Agreement with Novavax ContractPharma
November 17, 2021
Alcami, a U.S.-based CDMO, has signed a master laboratory services agreement with Novavax, a biotechnology company developing next-generation vaccines for infectious diseases.
NII says Covaxin has cellular immune memory to COVID for at least six months ExpressPharma
November 17, 2021
Covaxin has immunological memory to SARS-CoV-2 and its variants of concern for at least up to six months, Pushkar Sharma, Director in-Charge, National Institute of Immunology (NII) said...
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated Drugs
November 16, 2021
For individuals vaccinated with mRNA COVID-19 vaccines, prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a lower risk for breakthrough infection...
AstraZeneca to transition to ‘modest profitability’ on future COVID-19 vaccine orders CPhIonline
November 16, 2021
AstraZeneca will start to receive a modest profit from its COVID-19 vaccine as part of a post-pandemic commercial approach, the Anglo-Swedish drugmaker announced at a press conference on Friday.